The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Hoffmann, Soren
    Lawyer born in May 1967
    Individual (1 offspring)
    Officer
    2024-07-05 ~ now
    OF - Director → CIF 0
  • 2
    SjÖstrÖm, Christina Sofie
    Group Accounting Manager born in April 1977
    Individual (1 offspring)
    Officer
    2024-02-28 ~ now
    OF - Director → CIF 0
Ceased 12
  • 1
    Scanlan, Charles Denis
    Retired born in December 1944
    Individual
    Officer
    2014-03-11 ~ 2016-07-19
    OF - Director → CIF 0
  • 2
    Scanlan, Christopher Neil, Dr
    Research Scientist born in August 1977
    Individual
    Officer
    2013-01-15 ~ 2013-05-05
    OF - Director → CIF 0
  • 3
    Bjorne, Emanuel Fredrik
    Vice President born in July 1973
    Individual
    Officer
    2018-01-10 ~ 2020-02-05
    OF - Director → CIF 0
  • 4
    Laing, Peter
    Pharmaceutical Executive born in August 1956
    Individual (1 offspring)
    Officer
    2013-02-15 ~ 2013-08-21
    OF - Director → CIF 0
  • 5
    Spota, Donato
    Cfo born in August 1971
    Individual
    Officer
    2020-02-05 ~ 2024-02-28
    OF - Director → CIF 0
  • 6
    Tomasson, Ludvik Karl
    Head Of Finance / Certified Public Accountant born in January 1966
    Individual
    Officer
    2020-02-05 ~ 2023-08-31
    OF - Director → CIF 0
  • 7
    Joed, Eva-maria Viktoria
    Cfo born in April 1969
    Individual
    Officer
    2018-01-10 ~ 2020-02-05
    OF - Director → CIF 0
  • 8
    Arvidsson, Nils Göran
    Ceo born in March 1960
    Individual
    Officer
    2016-07-19 ~ 2017-11-07
    OF - Director → CIF 0
  • 9
    Crispin, Raymond John, Dr
    Business Developer born in November 1949
    Individual
    Officer
    2013-01-15 ~ 2016-07-19
    OF - Director → CIF 0
  • 10
    Winter, Ferdinand Gregor
    General Counsel born in November 1981
    Individual
    Officer
    2023-08-30 ~ 2024-07-05
    OF - Director → CIF 0
  • 11
    Crispin, Matthew David Max, Dr
    Research Scientist born in November 1978
    Individual
    Officer
    2013-01-15 ~ 2016-07-19
    OF - Director → CIF 0
    Dr Matthew David Max Crispin
    Born in November 1978
    Individual
    Person with significant control
    2016-04-06 ~ 2016-07-19
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 12
    Po Box 785, Lund, Se-220-07, Sweden
    Corporate
    Person with significant control
    2016-07-19 ~ 2016-07-19
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
parent relation
Company in focus

HANSA BIOPHARMA LIMITED

Previous names
IMMAGO BIOSYSTEMS LIMITED - 2019-02-08
OXFORD ANTIBODIES LIMITED - 2013-10-09
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Intangible Assets
2,057 GBP2022-12-31
2,278 GBP2021-12-31
Debtors
245,503 GBP2022-12-31
125,913 GBP2021-12-31
Cash at bank and in hand
21,777 GBP2022-12-31
16,945 GBP2021-12-31
Current Assets
267,280 GBP2022-12-31
142,858 GBP2021-12-31
Creditors
Current, Amounts falling due within one year
-161,083 GBP2022-12-31
-102,464 GBP2021-12-31
Net Current Assets/Liabilities
106,197 GBP2022-12-31
40,394 GBP2021-12-31
Total Assets Less Current Liabilities
108,254 GBP2022-12-31
42,672 GBP2021-12-31
Equity
Called up share capital
10 GBP2022-12-31
10 GBP2021-12-31
10 GBP2020-12-31
Share premium
19,998 GBP2022-12-31
19,998 GBP2021-12-31
19,998 GBP2020-12-31
Other miscellaneous reserve
496,169 GBP2022-12-31
323,995 GBP2021-12-31
174,770 GBP2020-12-31
Retained earnings (accumulated losses)
-407,923 GBP2022-12-31
-301,331 GBP2021-12-31
-181,766 GBP2020-12-31
Equity
108,254 GBP2022-12-31
42,672 GBP2021-12-31
13,012 GBP2020-12-31
Profit/Loss
Retained earnings (accumulated losses)
-602,762 GBP2022-01-01 ~ 2022-12-31
-119,565 GBP2021-01-01 ~ 2021-12-31
Profit/Loss
-602,762 GBP2022-01-01 ~ 2022-12-31
-119,565 GBP2021-01-01 ~ 2021-12-31
Average Number of Employees
62022-01-01 ~ 2022-12-31
62021-01-01 ~ 2021-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
4,138 GBP2021-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
2,081 GBP2022-12-31
1,860 GBP2021-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Patents/Trademarks/Licences/Concessions
221 GBP2022-01-01 ~ 2022-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
2,057 GBP2022-12-31
2,278 GBP2021-12-31
Amounts Owed By Related Parties
241,528 GBP2022-12-31
Current
123,462 GBP2021-12-31
Other Debtors
Amounts falling due within one year
3,975 GBP2022-12-31
2,451 GBP2021-12-31
Debtors
Current, Amounts falling due within one year
245,503 GBP2022-12-31
125,913 GBP2021-12-31
Trade Creditors/Trade Payables
Current
3,282 GBP2022-12-31
828 GBP2021-12-31
Corporation Tax Payable
Current
8,147 GBP2022-12-31
6,773 GBP2021-12-31
Other Taxation & Social Security Payable
Current
4,626 GBP2022-12-31
0 GBP2021-12-31
Other Creditors
Current
145,028 GBP2022-12-31
94,863 GBP2021-12-31
Creditors
Current
161,083 GBP2022-12-31
102,464 GBP2021-12-31
  • HANSA BIOPHARMA LIMITED
    Info
    IMMAGO BIOSYSTEMS LIMITED - 2019-02-08
    OXFORD ANTIBODIES LIMITED - 2013-10-09
    Registered number 08361712
    Ashcombe Court, Woolsack Way, Godalming, Surrey GU7 1LQ
    Private Limited Company incorporated on 2013-01-15 (12 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-15
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.